CII
DGX icon

CR Intrinsic Investors’s Quest Diagnostics DGX Stock Holding History

CR Intrinsic Investors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-150,000
Closed -$8.69M – 54
2014
Q1 		$8.69M Buy
+150,000
New +$8.04M 0.33% 106
2013
Q3 		– Sell
-75,000
Closed -$4.55M – 358
2013
Q2 		$4.55M Buy
+75,000
New +$4.47M 0.16% 191

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CR Intrinsic Investors's DGX Position: Q2 2014 in Review

CR Intrinsic Investors sold out of Quest Diagnostics (DGX) in Q2 2014, closing a stake of 150,000 shares — an estimated $8.69M sold.

CR Intrinsic Investors first reported a position in DGX in Q2 2013 and held it in 2 quarters. The position peaked at $8.69M in Q1 2014. 496 funds tracked by Wall St. Rank hold DGX as of Q2 2014.

  • CR Intrinsic Investors reported no remaining Quest Diagnostics position as of Q2 2014 after selling out during the quarter.
  • CR Intrinsic Investors sold 150,000 Quest Diagnostics shares in Q2 2014, an estimated $8.69M.
  • CR Intrinsic Investors first reported a position in Quest Diagnostics in Q2 2013 and held it in 2 quarters.
  • CR Intrinsic Investors's Quest Diagnostics position peaked at $8.69M in Q1 2014.
  • 496 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2014.

Based on CR Intrinsic Investors's 13F filing for Q2 2014.